Analytical Services CDMOs

Gland Pharma

Belgium

Gland Pharma is one of the largest generic injectable manufacturing companies globally, established in Hyderabad, India in 1978. The company operates under a B2B/CDMO business model with four cGMP-compliant formulation facilities and four API facilities, supplying products across 60 countries. It focuses on sterile injectables, oncology, and ophthalmics, including complex injectables and 505(b)(2) filings.

Gracure Pharmaceuticals Ltd

India

Gracure Pharmaceuticals Ltd is an Indian pharmaceutical company offering contract development and manufacturing services for finished dosage forms. The company manufactures oral solid dosage forms, liquids, and semi-solid products from WHO GMP and EU GMP-certified facilities, serving regulated and semi-regulated export markets. It provides formulation development, analytical testing, and commercial-scale manufacturing.

Grifols (Grifols Partnership)

Spain

Grifols Partnership is the CDMO arm of Grifols, a Spanish multinational with over 100 years of pharmaceutical experience, specializing in added-value small molecule injectable products manufactured in flexible bags and vials. The company operates FDA-approved manufacturing facilities and serves mid-size, large, and generic pharmaceutical companies with sterile parenteral drug products, including terminal sterilization and Form-Fill-Seal processes.

Grupo Ferrer Internacional, S.A. (Ferrer)

Spain

Grupo Ferrer Internacional (Ferrer) is a Spanish pharmaceutical company with certified production plants in Spain and the United States that manufactures chemical substances, APIs, and finished pharmaceutical products both for its own portfolio and for third parties under contract. The company's FDA registration is for API manufacture and analysis, and its website explicitly states it manufactures for third parties.

HALIX

Netherlands

HALIX is a biologics CDMO based in Leiden, Netherlands, specializing in end-to-end development and GMP manufacturing of viral vectors, vaccines, and recombinant proteins. The company operates a 6,700 square meter cGMP facility at the Leiden Bio Science Park with 10 clean rooms and 7 bioreactors. HALIX successfully manufactured the AstraZeneca COVID-19 vaccine at commercial scale and serves over 75 customers with a 90% retention rate.

Hanmi Pharm. Co. Ltd

South Korea

Hanmi Pharmaceutical is a major South Korean pharmaceutical company providing comprehensive CDMO services across the entire pharmaceutical lifecycle. The company operates through Paltan Smart Plant (producing 6+ billion chemical drug tablets annually), Pyeongtaek Bioplant (FDA-approved biopharmaceutical manufacturing with 12,500L bioreactors), and Hanmi Fine Chemical (API and raw materials including mRNA cap analogs, NTP, and lipids). Hanmi has partnerships with global pharma companies including Lilly, Roche, and Sanofi.

Harman Finochem Ltd

India

Harman Finochem Ltd is an India-based CDMO/CMO specializing in the manufacture and export of Active Pharmaceutical Ingredients, with core competencies in Metformin HCl, Fenofibrate, Divalproex Sodium, and over 45 other APIs. The company also operates a finished dosage form facility with EU GMP approval, capable of producing 2 billion tablets per year.

Health Biotech Limited

India

Health Biotech Limited is an Indian pharmaceutical manufacturer and exporter specializing in finished dosage forms across multiple formats including tablets, capsules, nasal sprays, ointments, creams, and liquid orals. The company serves global markets and provides contract manufacturing services.

Hebei Changshan Biochemical Pharma Co. Ltd

China

Hebei Changshan Biochemical Pharmaceutical Co., Ltd., founded in 2000, is a leading Chinese manufacturer of heparin and related products. The company has a complete heparin industry chain from crude products to APIs to finished injectable preparations, including heparin sodium APIs, low molecular weight heparin calcium injections, and sodium hyaluronate.

Hennig Arzneimittel GmbH & Co. KG

Germany

Hennig Arzneimittel GmbH & Co. KG is a German family-owned pharmaceutical company with over 120 years of experience, based in Floersheim am Main near Frankfurt. The company operates as both a branded pharmaceutical manufacturer and CDMO, specializing in solid dosage forms including sustained-release tablets, pellets, granules, and capsules. Acquired by Italian company Polifarma S.p.A. in January 2025.

Hikma Pharmaceuticals

Algeria

Hikma Pharmaceuticals is a global pharmaceutical company with 29 manufacturing plants across the US, Europe, and MENA, producing injectable, oral, and respiratory medicines. The company offers CMO services and has announced a $1 billion investment by 2030 to expand US manufacturing and R&D capabilities. Hikma has 76 FDA-approved products, produces 500 million injectable units annually, and has maintained zero critical FDA observations in 20+ years.

HIPRA Biotech Services

Spain

HIPRA Biotech Services is the CDMO division of HIPRA, a Spanish biopharmaceutical company with over 50 years of experience in vaccine research, production, and commercialization. The CDMO unit offers comprehensive biologics contract development and manufacturing services across mammalian, avian, and insect cell culture, microbial fermentation (E. coli, yeast), and aseptic fill-and-finish. HIPRA has experience with over 300 biological entities and demonstrated rapid development capability during COVID-19 vaccine production.

Hiral Labs Ltd

India

Hiral Labs Ltd is an Indian pharmaceutical contract manufacturer established in 2000, based near Roorkee, Uttarakhand. The company operates two WHO-GMP and ISO-certified manufacturing sites producing liquid injections, tablets, capsules, ointments, syrups, eye/ear drops, and oncology injections (including lyophilized). Hiral Labs manufactures over 350 formulations on a contractual basis for more than 300 companies across approximately 4,000 brands.

IBSA Institut Biochimique SA

Italy

IBSA (Institut Biochimique SA) is a Swiss multinational pharmaceutical company founded in 1945 in Lugano, with products present in over 90 countries. The company develops and manufactures innovative pharmaceutical products across 10 therapeutic areas with proprietary drug delivery technologies, including oral films, patches, and gonadotropin purification processes. IBSA has FDA-approved products in multiple dosage forms.

IDT Biologika

Germany

IDT Biologika is a leading global biologics CDMO headquartered in Germany, specializing in end-to-end development and manufacture of viral vaccines, gene and immune therapeutics, and aseptic fill-finish of sterile injectables. Founded in 1921 with over a century of experience in vaccines, the company operates BSL-2 facilities and has completed over 200 development, clinical, and commercial projects. IDT Biologika is a subsidiary of SK bioscience.

Inke S.A.

Spain

Inke S.A. is a Spanish API manufacturer headquartered in Barcelona with over 25 years of experience in micronization and complex chemical synthesis. The company operates 2 full cGMP manufacturing sites and specializes in high-quality APIs for inhalation (12 respiratory APIs), ophthalmic (6 high-potency APIs), and CNS therapies. Inke is FDA-registered and has SafeBridge-certified OEB 4 high-containment capabilities for HPAPIs.

Innova Captab Ltd

India

Innova Captab Ltd is the second largest domestic formulations CDMO in India, providing contract development and manufacturing services across tablets, capsules, dry syrups, ointments, liquid orals, and dry powder injections. The company operates five state-of-the-art facilities with nine independent manufacturing blocks in Baddi, Dehradun, Taloja, and Kathua, serving 14 of the top 15 Indian pharmaceutical companies.

Insud Pharma

Argentina

Insud Pharma is a large, diversified Spanish multinational pharmaceutical group with over 45 years of experience, 10,000 professionals, and 20 industrial plants across more than 50 countries. The company operates API manufacturing, oral solid dose, and injectable manufacturing through its CMO division (Chemo CMO), and biologics/biosimilar manufacturing through its biotech unit mAbxience (majority stake sold to Fresenius Kabi in 2022).

Intas Pharmaceuticals

India

Intas Pharmaceuticals is a leading vertically integrated pharmaceutical company headquartered in Ahmedabad, India, with CDMO capabilities spanning API manufacturing through finished formulations. The company operates 14 manufacturing facilities globally (11 in India, plus UK and Mexico), serving 85+ countries with particular strength in oncology, biosimilars, and plasma-derived therapies. Its flagship Pharmez 2 facility can produce over 1 billion solid oral units monthly and 5 million injectable units.

Intavis Peptide Services GmbH

Germany

Intavis Peptide Services GmbH is a Tubingen, Germany-based biotech company specializing in custom peptide synthesis for laboratory research and clinical trials. Founded in 2019 with over 30 years of peptide synthesis expertise, the company provides GMP-grade peptide production and aseptic fill and finish services, with a focus on neoantigen peptide cancer vaccines.

Intravacc

Netherlands

Intravacc is a Netherlands-based vaccine CDMO founded in 2013 with ~200 employees, specializing in vaccine development from discovery through Phase II clinical trials. The company provides cGMP manufacturing of bacterial, viral, conjugate, and oncological vaccines using mammalian and microbial fermentation systems (up to 200L single-use bioreactors), along with comprehensive analytical services and proprietary vaccine platforms including Outer Membrane Vesicle (OMV) technology.

Isotopia Molecular Imaging Ltd

Germany

Isotopia Molecular Imaging Ltd is a global leader in radiopharmaceuticals, developing, producing, and distributing diagnostic and therapeutic isotopes including Gallium-68, Terbium-161, and Lutetium-177 products. The company offers CMO services for sterile drug manufacturing through its aseptic plant and is FDA-registered with manufacturing operations in Israel and Germany.

JCR Pharmaceuticals

Japan

JCR Pharmaceuticals is a Japanese pharmaceutical company and CDMO founded in 1975, with nearly 50 years of experience in rare disease treatments and orphan drug production. Selected for Japan's Regenerative Medicine CDMO Subsidy Program in 2025, the company is expanding biomanufacturing infrastructure for cell, gene, and regenerative medicine therapies. JCR operates five production sites and has proprietary platforms including JUST-AAV for gene therapy and J-Brain Cargo for blood-brain barrier penetration.

Jerome Stevens Pharmaceuticals, Inc.

United States

Jerome Stevens Pharmaceuticals, Inc. (JSP) is a family-owned pharmaceutical manufacturer based in Bohemia, New York, established in 1979. The company specializes in manufacturing prescription tablet and capsule formulations under cGMP standards. JSP is notable for manufacturing UNITHROID, the first FDA-approved Levothyroxine Sodium product, and also produces Digoxin tablets. The company provides CMO services to partners including Amneal Pharmaceuticals.

Jiangsu Nhwa Pharmaceutical Co., Ltd.

China

Jiangsu Nhwa Pharmaceutical Co., Ltd. is a leading Chinese pharmaceutical company specializing in CNS (Central Nervous System) drugs, listed on Shenzhen Stock Exchange (002262.SZ) since 2008. Founded in 1978, the company is designated as a national production unit for narcotic and psychotropic drugs. Nhwa operates over 10 automated production lines for tablets, capsules, liquid injectables, and powder injectables, covering over 800 acres. The company serves as a major global CNS drug production and R&D base.

Jiangxi Tianxin Pharmaceutical Co., Ltd.

China

Jiangxi Tianxin Pharmaceutical Co., Ltd. is a Chinese high-tech pharmaceutical company established in 2004, located in Le'anjiang Industrial Zone, Leping, China. The company specializes in manufacturing active pharmaceutical ingredients, particularly vitamins (Vitamin D), and supplies APIs and intermediates for the alimentary tract, metabolism, and infectious disease therapeutic areas. Tianxin has extensive FDA registration with 15 FEI numbers and 2 FDA-approved products.

JOINN Biologics

China

JOINN Biologics is a full-service biologics CDMO providing end-to-end development and manufacturing services for complex biologics modalities. Led by US-based development and management leadership, the company operates multi-site facilities in Richmond and Sacramento, California, and acquired Lonza's 183,000 sq ft manufacturing facility in Guangzhou, China. JOINN Biologics is integrated with its sister CRO, JOINN Labs, offering a seamless CRO-CDMO platform.

Laurus Synthesis

India

Laurus Synthesis is the CDMO subsidiary of Laurus Labs, a prominent Indian pharmaceutical and biotechnology company. It is a Contract Development and Manufacturing Organization with a solid track record in supporting drug development and commercial API supply. Serves as the US-affiliate of Laurus Labs, with key markets in the US, European Union, and Japan. Offers high-potent drug manufacturing capabilities and comprehensive CDMO services from drug substance development through commercial manufacturing.

Liof Pharma

Spain

Liof Pharma is a European CDMO headquartered in the Basque Country, Spain, specializing in aseptic manufacturing and lyophilization of sterile injectable biologics. With over 15 years of experience, the company provides clinical and commercial manufacturing of biologics drug products including monoclonal antibodies, peptides, proteins, mRNA, AAV viral vectors, and vaccines. The facility operates in compliance with EMA, FDA, ANVISA, and AEMPS regulations.

Lomapharm GmbH

Germany

Lomapharm GmbH is a German pharmaceutical contract manufacturer with 140+ years of experience (since 1878), offering services from development through production and packaging to market release. The company produces solid oral dosage forms (including micro-tablets) and aseptically manufactured sterile dosage forms such as preservative-free eye drops and nasal sprays. Lomapharm was formerly a subsidiary of Daicel Corporation before being transferred to Bionorica SE.

Lonza

Switzerland

Lonza is a pioneer and world leader in the CDMO industry, founded in Switzerland in 1897. The company provides integrated development and manufacturing services across biologics, small molecules, cell and gene therapy, mRNA, and bioconjugates (ADCs/HPAPIs). With over 20,000 employees across five continents, Lonza serves the global pharmaceutical, biotech, and nutrition industries with end-to-end capabilities from early development to commercial-scale manufacturing.

Medichem S.A.

Malta

Medichem S.A. is a family-owned, vertically integrated pharmaceutical company headquartered in Barcelona, Spain, with nearly 50 years of industry experience. The company delivers end-to-end solutions from API development to finished drug product manufacturing (oral and injectable). Their portfolio includes approximately 45 APIs and 20 finished dosage forms (FDF), supported by full regulatory dossiers. Medichem provides API and FDF CDMO solutions and is also a leader in antiseptic products. The company has 400 experienced professionals serving 600+ corporate customers across 60+ countries. Facilities include R&D centres in Barcelona, Celra, and Hal-Far (Malta), and manufacturing plants in Celra (Spain), Hal-Far (Malta), and a new sterile injectables facility in Llanera, Asturias (Medichem Solutions). Medichem also has commercial offices in New York and Nanjing.

Menarini Biotech

Italy

Menarini Biotech is a CDMO within the Menarini Group, specialized in process development and GMP manufacturing of biopharmaceuticals. Headquartered in the greater Rome area (Pomezia, Italy), the company has over 25 years of experience in biologics development and manufacturing, including monoclonal antibodies. Menarini Biotech provides services from cell line development through commercial-scale GMP production at its Italian pharmaceutical campus.

Milan Laboratories (India) Pvt. Ltd.

India

Milan Laboratories (India) Pvt. Ltd. is an Indian pharmaceutical manufacturer and exporter established in 1976, producing and exporting pharmaceutical formulations from WHO-cGMP compliant facilities. The company has 300+ marketing authorizations across 43+ countries. Milan has 9 FDA-registered FEI numbers, 65 FDA-approved products across multiple dosage forms (tablets, injectables, liposomal injectables, solutions, emulsions, powders), and has received 38 FDA inspections (14 NAI, 19 VAI, 5 OAI). The company has also had 16 Class II recalls. Milan provides regulatory consulting services and dossier preparation in ACTD, CTD, eCTD formats.

Minsheng Group Shaoxing Pharmaceutical Co., Ltd.

China

Minsheng Group Shaoxing Pharmaceutical Co., Ltd. is a Chinese API manufacturer established in 2002, subsidiary of Hangzhou Minsheng Pharmaceutical Holding Group. The company specializes in R&D and production of high-quality APIs for human and veterinary use, as well as intermediates and cell culture products. Over 50% of products are exported to Europe, the US, Japan and other developed countries. FDA-registered for API manufacture with 8 FDA inspections (3 NAI, 5 VAI).

MSN Laboratories

India

MSN Laboratories is a Hyderabad-based major pharmaceutical CDMO with $1.2 billion in revenue. The company operates 15 API facilities and 6 finished dosage form (FDF) facilities across India and the USA (Novadoz Pharmaceuticals). MSN offers CRAMS (Contract Research and Manufacturing Services) with 200+ first-to-market generics and 400+ formulations. Specialized capabilities include cytotoxics, high-potency APIs, peptides, prostaglandins, and biosimilars. FDA-registered with 14 FEI numbers, 31 FDA inspections (16 NAI, 15 VAI — strong track record), and 119 FDA-approved products. Has established an advanced E&L (Extractables and Leachables) Laboratory.

Nephron

United States

Nephron Pharmaceuticals is a US-based sterile pharmaceutical manufacturer and 503B outsourcing facility headquartered in West Columbia, South Carolina. The company specializes in generic respiratory medications (inhalation solutions and suspensions) and contract manufacturing of sterile pre-filled medications using blow-fill-seal (BFS) technology, producing over one billion doses annually.

NerPharMa srl (NMS Group)

Italy

NerPharMa is an Italian CDMO (part of NMS Group, acquired by Benta in 2026) specializing in highly potent compounds with strong expertise in oncology. It operates two divisions: Drug Substance (API manufacturing in high containment glove-box suites, 50-250L reactors, 0.5-5 kg batches) and Drug Product (injectable solutions, suspensions, lyophilized products, and oral solid dosage forms including cytotoxic and cytostatic products).

Nobel Ilac Sanayii Ve Ticaret A.S.

Kazakhstan

Nobel Ilac is a Turkish pharmaceutical company founded in 1964, operating in 20+ countries with representative offices and exporting drug substances and drug products to over 50 countries. The company manufactures both APIs and finished dosage forms, with biotechnology as a declared strategic priority. It is listed as a CMO/CDMO on PharmaSource with contract small molecule API manufacturing capabilities.

Normon

Spain

Laboratorios Normon is a Spanish pharmaceutical company manufacturing generic medicines. Founded as a family company, it has invested over 100 million euros in expansion and operates FDA-registered manufacturing facilities. The company is listed as a CMO/CDMO on PharmaSource and appears in cytotoxic drugs and HPAPI manufacturing market reports, indicating high-potency capabilities.

NorthStar Medical Radioisotopes, LLC

United States

NorthStar Medical Radioisotopes is a US-based commercial-stage company focused on the development, production, and commercialization of radiopharmaceuticals. Operating a dedicated Radiopharmaceutical CDMO/CMO on its 55-acre Beloit, Wisconsin campus, NorthStar develops novel non-reactor-based production processes for therapeutic and diagnostic radioisotopes including Molybdenum-99, Copper-67, and Actinium-225. The company has 14 FDA-approved products and a 52,000 sq ft purpose-built CDMO facility.

Novartis Contract Manufacturing

Austria

Novartis Contract Manufacturing is the CDMO arm of Novartis, offering fully integrated end-to-end manufacturing solutions across biologics (mammalian up to 15,000L, microbial up to 13,000L), small molecules (API to fill & finish), cell & gene therapy (CAR-T, AAV, LV), xRNA/LNP/pDNA, and comprehensive fill & finish services. The operation spans multiple state-of-the-art facilities across Austria, Switzerland, Slovenia, Belgium, France, Singapore, and the United States, with 107 FDA inspections and 27 FEI registrations.

Novell Pharmaceutical Laboratories

Indonesia

Novell Pharmaceutical Laboratories is one of the largest pharmaceutical companies in Indonesia, manufacturing both oral solid dosage forms (tablets, capsules, powders) and sterile injectable products (liquid and powder). The factory was originally built and operated by a multinational company, and later expanded to Australian TGA standards. The facility features Class A/B/C/D cleanrooms, Bausch & Stroebel filling equipment, Getinge autoclaves, and Lytzen depyrogenation ovens. Novell has 2 FDA-registered FEI numbers, 3 FDA-approved products, and 10 FDA inspections.

Novocol Pharma

Canada

Novocol Pharma is a CDMO headquartered in Cambridge, Ontario, Canada, specializing in sterile injectable fill-finish and combination drug product assembly. With over 40 years of experience, the company offers aseptic and terminally sterilized manufacturing from development through commercialization. Novocol Pharma is a Septodont company and has a fill-finish partnership with Moderna for mRNA vaccines.

Novugen Pharma

Malaysia

Novugen Pharma is a Malaysian pharmaceutical company and CDMO subsidiary of UAE-based SciTech International, providing vertically integrated API and finished dosage form development and manufacturing. The company has USFDA-approved facilities including a dedicated oncology manufacturing plant. Novugen achieved zero Form 483 citations from USFDA and holds Halal pharmaceutical certification.

Nucleus RadioPharma

United States

Nucleus RadioPharma is a US-based full-service CDMO dedicated to building clinical and commercial supply chains for targeted radiotherapies (radiopharmaceuticals). The company operates a cGMP-compliant facility in Rochester, MN with expansion sites under construction in Spring House, PA and Mesa, AZ, targeting over 100,000 square feet of purpose-built radiopharmaceutical development and manufacturing space.

Nuvisan

France

Nuvisan is a full-service CRO and CDMO headquartered in France with state-of-the-art laboratories in Germany and France. The company provides integrated drug discovery and development services spanning omics and biomarkers, compound screening, pharmacology, chemistry, preclinical safety, bioanalysis, clinical services (Phase 1 and 2), and CMC services including drug substance and drug product manufacturing, pharmaceutical analytical services, and clinical trial supply management.

OFD Life Sciences

India

OFD Life Sciences is a division of Oregon Freeze Dry, one of the largest and most experienced lyophilization companies, with over 60 years of freeze-drying expertise. The company provides comprehensive lyophilization services for biopharma, medtech, and consumer health sectors, from development through commercialization. Its proprietary LyoVantage platform supports cycle development and clinical trial and commercial-scale lyophilization.